2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Epilim should preferably be taken with or after food: the enteric-coated tablet (lilac) must be swallowed whole, if necessary with a little water: the plain tablet (white, 100 mg) may be taken
Download 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
FORMULATION AND IN-VITRO EVALUATION OF CAPTOPRIL …
jpsbr.orgJPSBR: Volume 2, Issue 3: May Jun 2012 (97-102) ISSN NO. 2271-3681 Patil B. S. et al 1 1
Metformin Hydrochloride Extended-Release Tablets 500 mg ...
lupinpharmaceuticals.comPage 1 of 22 Metformin Hydrochloride Extended-Release Tablets 500 mg and 1000 mg Rx only DESCRIPTION Metformin hydrochloride extended-release tablets …
Metex XR - Arrow Pharmaceuticals
www.arrowpharma.com.auMETAX XR- Product Information Page 1 of 9 Metex XR PRODUCT INFORMATION Life threatening lactic acidosis can occur due to accumulation of metformin.
Diaformin XR Diaformin - Medicines
www.medicines.org.auAUSTRALIAN PRODUCT INFORMATION Diaformin®XR Diaformin®XR 1000 Metformin hydrochloride extended release tablets Life threatening lactic acidosis can occur due to accumulation of metformin.
NEW ZEALAND DATA SHEET NAME OF MEDICINE
www.medsafe.govt.nz11 An increased number of ECL cells possibly related to the increased serum gastrin levels, and .
Public Assessment Report Decentralised Procedure Yaltormin ...
www.mhra.gov.ukPAR Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets UK/H/5957/001-3/DC 3 sugar produced in the liver and increases the sensitivity of muscle cells to insulin.
uk-mockup
www.medicines.org.ukPAGE 2 PAGE 3 • you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis
Package leaflet: Information for the patient Ranexa 375 mg ...
www.medicines.org.uk1 Package leaflet: Information for the patient Ranexa 375 mg prolonged-release tablets Ranexa 500 mg prolonged-release tablets Ranexa 750 mg prolonged-release tablets